Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -2.50% | -8.24% |
03-14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
03-14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 350M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Partners With Vaneltix Pharma to Develop, Commercialize Interstitial Cystitis Pain Treatment